Procell System

ProCell Therapeutics is a South Korean biotechnology company specializing in the development of advanced protein and peptide-based therapeutics using its proprietary PIPP (Protein Intracellular Delivery Technology) platform. The company's technology focuses on the efficient intracellular delivery of large therapeutic proteins, which are typically unable to cross cell membranes, thereby expanding the range of druggable intracellular targets. ProCell's pipeline includes programs for atopic dermatitis, hair loss, obesity, and various cancers, with its lead candidate for atopic dermatitis having reached clinical testing. Beyond drug development, the company leverages its delivery system for high-end cosmeceutical applications, providing a diversified revenue stream through the commercialization of bioactive ingredients.